The Latest Analyst Ratings for Medtronic
Portfolio Pulse from Benzinga Insights
In the last quarter, Medtronic (NYSE:MDT) received 2 bullish, 4 somewhat bullish, and 5 indifferent ratings from analysts. The company's average 12-month price target is $95.64, an increase of 7.11% from the previous average of $89.29.
July 19, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic received mostly bullish and indifferent ratings from analysts in the last quarter. The average 12-month price target for the company is $95.64, up 7.11% from the previous average.
The increase in the average price target and the mostly bullish ratings from analysts suggest a positive outlook for Medtronic. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100